Clinical Research Directory
Browse clinical research sites, groups, and studies.
Hybrid Florbetaben PET/MRI for Imaging of Cardiac Amyloidosis
Sponsor: University Hospital, Essen
Summary
Exploration of prognostic parameters in 18F-Florbetaben PET/MRI in patients with cardiac amyloidosis. The clinical endpoints are defined as occurence of major adverse cardiac events (MACE) in amyloidosis patients. Additionally, MACE outcome stratified by PET parameters will be evaluated and individual parameters of the imaging techniques will be compared to each other (PET, MRI or echocardiography).
Official title: Monocentric Observational Trial for Florbetaben PET/MRI Hybrid Imaging in Patients With Cardiac Amyloidosis
Key Details
Gender
All
Age Range
40 Years - Any
Study Type
OBSERVATIONAL
Enrollment
25
Start Date
2019-12-09
Completion Date
2025-12
Last Updated
2025-09-04
Healthy Volunteers
No
Conditions
Locations (1)
Department of Nuclear medicine, University Hospital Essen
Essen, North Rhine-Westphalia, Germany